Wells Fargo & Company »

Sutro Biopharma shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2k 100 11.57

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom Put Option (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Call Option (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)

View all positions for Wells Fargo & Company

Top funds holding Sutro Biopharma

Affinity Asset Advisors
Kynam Capital Management
Vanguard Group
Acadian Asset Management
Velan Capital Investment Management
Vestal Point Capital
Samsara BioCapital
Eversept Partners
Opaleye Management
Point72 Asset Management
Tang Capital Management
Renaissance Technologies
BlackRock
GSA Capital Partners
Marshall Wace

View all funds holding Sutro Biopharma